Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure

Bibliographic Details
Main Authors:	Sam Hanon, Pugazhendi Vijayaraman, Edmund H Sonnenblick, Thierry H Le Jemtel
Format:	Article
Language:	English
Published:	Hindawi - SAGE Publishing 2000-06-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.3317/jraas.2000.018

Similar Items

Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014-03-01)

Homologues of the angiotensin converting enzyme
by: Elliott, Joann Louise
Published: (2005)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
by: Kathryn M Meurs, et al.
Published: (2017-10-01)

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
by: Darcy Adin, et al.
Published: (2020-03-01)

Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
by: Jiang Wang, et al.
Published: (2015-09-01)

Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
by: Mizuo Miyazaki, et al.
Published: (2006-01-01)

Angiotensin-converting Enzyme Genetic Polymorphism
by: Somsri Wiwanitkit, et al.
Published: (2014-06-01)

Studies on the inhibitors of angiotensin converting enzyme
by: Hodsman, G. P.
Published: (1983)

Angiotensin converting enzyme and endothelial dysfunction
by: Prasad, Abhiram
Published: (2001)

Novel findings: Expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in thoracic aortic dissection and aneurysm
by: Yang Li, et al.
Published: (2015-12-01)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
by: Gábor Kriszta, et al.
Published: (2021-03-01)

Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung
by: Ryuta Baba, et al.
Published: (2020-10-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blockers and Pneumonia risk
by: Chia-Lin Liu, et al.
Published: (2010)

The polymorphisms in angiotensin-converting enzyme and angiotensin-converting enzyme 2 are not associated with thoracic aortic diseases and coronary heart disease
by: Yang Li, et al.
Published: (2016-09-01)

Angiotensin converting enzyme inhibitory activity of kefir and expression of recombinant angiotensin converting enzyme inhibitory peptide in Escherichia coli
by: Yen-Po Chen, et al.
Published: (2004)

Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis
by: Zoltán Kiss, et al.
Published: (2015-12-01)

Correlation between plasma-soluble angiotensin-converting enzyme 2, anti- angiotensin-converting enzyme 2, and angiotensin-(1–7) in patients with chronic heart failure
by: Yi Gu, et al.
Published: (2019-01-01)

Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury
by: P R Shah, et al.
Published: (2011-01-01)

Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I–Infused Rats
by: Keisuke Ohnishi, et al.
Published: (2013-01-01)

Interplay of Angiotensin II and Angiotensin 1-7 in the Modulation of Cardiac Angiotensin-Converting Enzyme II of Human Cardiofibroblasts
by: Wen, Cheng-Hao, et al.
Published: (2009)

Rat angiotensin-converting enzyme : tissue specific expression during pharmacological inhibition
by: Brice, Edmund Andrew William
Published: (2018)

Characterisation of the ectodomain shedding of angiotensin-converting enzyme
by: Woodman, Zenda
Published: (2014)

Angiotensin-converting enzyme polymorphism and pediatric pneumonia
by: Nihal El Rifai, et al.
Published: (2018-12-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

Angiotensin-Converting Enzyme 2: The First Decade
by: Nicola E. Clarke, et al.
Published: (2012-01-01)

Angiotensin converting enzyme inhibition of tempeh hydrolysates
by: Yun Ling Tseng, et al.

Angiotensin converting enzyme inhibition of tempeh hydrolysates
by: Yun Ling Tseng, et al.
Published: (2009)

Angiotensin-converting enzyme in cardiovascular function and dysfunction
by: Ljungberg, Liza
Published: (2011)

Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme?
by: Duncan J Campbell
Published: (2012-06-01)

The influence of circulating angiotensin-converting enzyme activity and angiotensin-converting enzyme genotype on endurance and strength performance in previously sedentary humans
by: Day, Stephen Howard
Published: (2005)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
by: Zhang C, et al.
Published: (2021-02-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
by: Letian Zhou, et al.
Published: (2014-03-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01)

Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
by: Özlem Bozkurt, et al.
Published: (2009-06-01)